Gameto CEO Dina Radenkovic talks about running a women's health biotech, the development of Fertilo, work on menopause, and more
She describes how Fertilo is being developed to replace hormonal injections and shorten IVF and egg freezing times. Plus, how recent fundraising will allow the company to reopen its work on menopause, and why we need more women's health biotechs.
Comments